Viewing Study NCT05983250


Ignite Creation Date: 2025-12-24 @ 4:47 PM
Ignite Modification Date: 2026-01-04 @ 6:57 AM
Study NCT ID: NCT05983250
Status: RECRUITING
Last Update Posted: 2025-12-18
First Post: 2023-08-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF
Sponsor: Tenax Therapeutics, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module